Abstract
Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.
Original language | English |
---|---|
Pages (from-to) | 392-396 |
Number of pages | 5 |
Journal | Maturitas |
Volume | 75 |
Issue number | 4 |
Early online date | 27 Jun 2013 |
DOIs | |
Publication status | Published - 1 Aug 2013 |
Bibliographical note
The guideline development process was conducted without financial support from any commercial organisation and the members of the National Osteoporosis Guideline Group have maintained complete editorial independence.Keywords
- Fracture
- FRAX
- Guideline
- Osteoporosis